Literature DB >> 8322230

Do bronchodilators adversely affect the prognosis of bronchial hyperresponsiveness?

C P van Schayck, C L van Herwaarden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8322230      PMCID： PMC464495          DOI： 10.1136/thx.48.5.470

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  31 in total

1.  Bronchial reactivity to inhaled histamine: a method and clinical survey.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Clin Allergy       Date:  1977-05

Review 2.  Is current treatment increasing asthma mortality and morbidity?

Authors:  E A Mitchell
Journal:  Thorax       Date:  1989-02       Impact factor: 9.139

3.  Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline.

Authors:  A S Vathenen; A J Knox; B G Higgins; J R Britton; A E Tattersfield
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

4.  Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

Authors:  J Kraan; G H Koëter; T W vd Mark; H J Sluiter; K de Vries
Journal:  J Allergy Clin Immunol       Date:  1985-10       Impact factor: 10.793

5.  Formoterol, a new long-acting bronchodilator for inhalation.

Authors:  P Arvidsson; S Larsson; C G Löfdahl; B Melander; L Wåhlander; N Svedmyr
Journal:  Eur Respir J       Date:  1989-04       Impact factor: 16.671

6.  Effects of long-term treatment with inhaled cromoglycate and budesonide on bronchial hyperresponsiveness in patients with allergic asthma.

Authors:  J Molema; C L van Herwaarden; H T Folgering
Journal:  Eur Respir J       Date:  1989-04       Impact factor: 16.671

7.  Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study.

Authors:  J Crane; N Pearce; A Flatt; C Burgess; R Jackson; T Kwong; M Ball; R Beasley
Journal:  Lancet       Date:  1989-04-29       Impact factor: 79.321

8.  A comparison of the effects of nedocromil sodium and beclomethasone dipropionate on pulmonary function, symptoms, and bronchial responsiveness in patients with asthma.

Authors:  U G Svendsen; L Frølund; F Madsen; N H Nielsen
Journal:  J Allergy Clin Immunol       Date:  1989-08       Impact factor: 10.793

9.  Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma but oral theophylline does not.

Authors:  J I Dutoit; C M Salome; A J Woolcock
Journal:  Am Rev Respir Dis       Date:  1987-11

10.  Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma.

Authors:  K F Kerrebijn; E E van Essen-Zandvliet; H J Neijens
Journal:  J Allergy Clin Immunol       Date:  1987-04       Impact factor: 10.793
View more
  3 in total

Review 1.  Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?

Authors:  B J Lipworth
Journal:  Drug Saf       Date:  1997-05       Impact factor: 5.228

Review 2.  The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.

Authors:  M R Sears; D R Taylor
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

Review 3.  Major reduction in asthma morbidity and continued reduction in asthma mortality in New Zealand: what lessons have been learned?

Authors:  J Garrett; J Kolbe; G Richards; T Whitlock; H Rea
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.